At this conference we focus on initiatives in academia and industry and the need for collaboration as well as framework conditions needed to put research to use for the benefit of patients and society.
Watch video with pictures of all who were on stage (3 minute and 4 seconds with music).
Programme
08:00–08:30 Registration and breakfast
Place: Area outside Forum auditorium
08:30–10:00 Impact Breakfast: Antimicrobial resistance – a global challenge with urgent need for new solutions
Place: Area outside Forum auditorium
- Welcome to Science Impact 2025
Jens Petter Berg, Vice-Rector for life science and health research, University of Oslo - Antibiotic resistance – how worried should we be?
Kristian Tonby, MD, PhD, associate professor, Institute of Clinical Medicine, UiO and Oslo University Hosptial (OUS) - New therapy against drug-resistant tuberculosis
Tone T?njum, Professor, Institute of Clinical Medicine, UiO and OUS - What does it take to develop a new antibiotic? – from bioprospecting to AI-supported identification
Geir Klinkenberg, research manager, SINTEF - Inventing and developing novel resistance breakers
Bj?rn Klem, COO, AdjuTec Pharma AS - Precision-guided missiles to target harmful bacteria
Jukka Corander, Institute of Basic Medical Sciences, UiO - Developing diagnostic device to detect drug resistant bacteria
Elizaveta Vereshchagina, PhD, senior research scientist, SINTEF - Development of new antibiotics from the perspectives of a large pharmaceutical company
Kristin L?seth, medical director Norway, AstraZeneca
Chairperson: Jens Petter Berg, Vice-Rector for life science and health research, University of Oslo
10:00–10:30 Networking
10:30–12:00 Parallel sessions
Cancer treatment – Oslo a world-leading hub for radiopharmacy
Place: Forum auditorium
- Theranostics – targeted radionuclide therapy
Mona Elisabeth Rootwelt-Revheim, MD, PhD, professor II, head of The Intervention Centre, UiO and OUS - Building competence and infrastructure on radionuclides
Sunniva Siem, professor Department of Physics UiO, and centre director, the Norwegian Nuclear Research Centre - Transforming cancer care through direct alpha therapy
?ystein Soug, CEO, Oncoinvent -
Challenging cancer indications met with challenging technology
Marion Malenge, head of in vivo radiopharmaceutical development, ARTBIO - Development of radionuclides from the perspectives of a large pharmaceutical company
Jenny Karlsson, senior director targeted radiopharmaceuticals, Bayer - Empowering innovation: The Oslo Imaging and Therapy Laboratory’s support for public and private radiopharmaceutical development
Syed Nuruddin, Preclinical research Manager, The Cyclotron Center and, Associate Professor II, Department of Pharmacy, UiO - Development of a novel targeted radionuclide therapeutic for haematological malignancies, Ada Repetto-Llamazares, PhD, CSO, NucliThera
Chairperson: Ole Kristian Hjelstuen, CEO Inven2
Materials science advancing medical research and development
Place: Toppsenteret
- New technology for precision human tissue and modeling of neurodegenerative diseases
Joel Glover, professor, Institute of Basic Medical Sciences, UiO, Kaja Nordengen, MD, Phd, senior physician, OUS and Michal Mielnik, research manager, SINTEF - PharmaChip: Robust, automated, and sustainable chemical analysis of organoids and organ-on-chip systems
Steven Ray Wilson, professor, Department of Chemistry, UiO and Fr?ydis Sved Skottvoll, PhD, research scientist, SINTEF - Towards more flexible, biocompatible and less invasive brain implants
Florian Dapsance, PhD candidate, Department of Physics, UiO - BreathSense – transforming COPD patient care with ground-breaking hand-held breath diagnostics sensor technology
Elizaveta Vereshchagina, PhD, senior research scientist, SINTEF - Intensive care monitoring of glucose, Nicolas Elvemo, CEO, GlucoSet
Chairperson: Charlotte Berrefjord Bergl?ff, Senior Communications Adviser, SINTEF Digital
12:00–13:00 Networking and lunch
Place: Area outside Forum auditorium and Toppsenteret
13:00–14:30 Parallel sessions
Neuroscience – better diagnosis and treatment of Alzheimer's, Parkinson's and multiple sclerosis
Place: Forum auditorium
- Global and national perspectives on a growing challenge – what has been, what is and what will be?
Geir Selb?k, MD, PhD, professor II, Institute of Clinical Medicine, UiO, and research director, The Norwegian National Centre for Ageing and Health - Modeling brain disease using organoids,
Magnar Bj?r?s, PhD, researcher, Institute of Clinical Medicine, UiO and OUS and professor, NTNU - Therapeutic trials and vaccine studies in multiple sclerosis (MS)
Gro Owren Nygaard, MD, PhD, researcher, Institute of Clinical Medicine, UiO and OUS - Ongoing clinical studies on Alzheimer's disease
Anne-Brita Knapskog, MD, PhD, senior consultant, Oslo University Hospital - Challenges and success factors in drug development for neurodegenerative disorders
Susanne Fabre, PhD, senior director translational biomarkers and bioanalysis, BioArctic - Personalized neuro diagnostics with AI
Guro Seternes, CTO, baba - Deep brain stimulation therapy for Parkinson's
J?rn Thomas Waagb?, therapy specialist, Medtronic - New challenges, new opportunities: biomarkers in the fight against Alzheimer’s disease
María José Lagartos Donate, senior scientist, Pre Diagnostics
Chairperson: Hanne Flinstad Harbo, professor, dean, the Faculty of Medicine, UiO
Research in use – how to create impact through social innovation
Place: Toppsenteret
Part 1: Social innovation – what is it?
Panel discussion moderated by Markus Bugge, associate professor, TIK Centre for Technology, Innovation and Culture, UiO
- Introduction by Taran Thune, professor, TIK Centre for Technology, Innovation and Culture, UiO
- Examples from SPARK Social Innovation
- LangCom: The Language Community Web Platform Pilot, Veslem?y Rydland, Department of Education, UiO
- RecoVRy: Artificial Intelligence powered Virtual Reality Therapy in Psychosis Treatment
June Ullevolds?ter Lystad, researcher, Oslo University Hospital and Associate Professor, Department of Psychology, UiO - Data-informed Reflection Tool for Teamwork Simulation Training (SIMTEAM), Crina Damsa, Department of Education, UiO
Part 2: The user side of social innovation
Panel discussion moderated by Silje Tellmann, associate professor, TIK Centre for Technology, Innovation and Culture, UiO and Department of Business, History and Social Sciences, University of South-Eastern Norway
- Introduction by Magnus Gulbrandsen, professor, TIK Centre for Technology, Innovation and Culture, UiO
-
Torunn Tjelle, Special Advisor, The Norwegian Cancer Society,
-
Henrik Dons Finsrud, Norwegian Association of Local and Regional Authorities (KS)
-
Kari-Elisabeth Vambeseth Skogen, senior adviser, Ministry of Education and Research
14:30–15:00 Networking
Place: Area outside Forum auditorium and Toppsenteret
15:00–16:30 Impact Afternoon: Women's health research and development
Place: Forum auditorium
- A new approach to understanding women's heart health
Mathis Korseberg Stokke, MD, PhD, professor, Institute of Clinical Medicine, UiO and OUS and Stine Aagaard-Nilsen, medical research curriculum student, UiO - Imaging pregnancies with new AI-technologies
Anne Eskild, MD, PhD, professor II, Institute of Clinical Medicine, UiO and Akershus University Hospital (Ahus) - R&D on women's health: Migraine and beyond
Maria Holmqvist T?ngefjord, Medical Director Scandinavia, AbbVie - Developing new methods to diagnose and treat endometriosis
Hanne Haslene-Hox, PhD, senior research scientist, SINTEF - Bed-side test to determine fertile days and improve IVF outcome
Peter Fedorcsak, MD, PhD, professor II, Institute of Clinical Medicine, UiO and OUS - Shaping Health for Women – Case Bayer
Manja Ahola, Head Device Processes for Medical Device and Combination Products, Bayer - Overcoming resistance in breast cancer: a new targeted therapy approach
Esmaeil Dorraji, PhD, CSO and founder, Immunoquest Therapeutics AS - Gender differences in stroke
Helge Fagerheim Bugge, MD, PhD candidate, UiO, OUS and The Norwegian Air Ambulance Foundation - Closing remarks
Hilde Nebb, professor, innovation director, UiO Growth House
Chairperson: Chelsea Ranger, founder & chair, Women in Life Science Norway (Wild Norway)
16:30–17:00 Networking with refreshments
Place: Area outside Forum auditorium
Organisers
Main organiser: UiO Growth House
Internal partners at the University of Oslo (UiO): Faculty of Medicine, Faculty of Mathematics and Natural Sciences, Centre for Global Sustainability, Department of Informatics, Centre for Materials Science and Nanotechnology and SPARK Social Innovation
External partners: Inven2, SINTEF, The Life Science Cluster, Nansen Neuroscience Network, Oslo Cancer Cluster, LMI, Oslo University Hospital (OUS), Oslo Science City and Oslo Science Park
Questions?
Please contact the UiO Growth House, Norunn K. Torheim, Head of communications and public and external relations, at norunnt@uio.no
See the programme and pictures from Science Impact 2024 and Science Impact 2023.